CXCR4 overexpression was associated with both PFS and OS in seven subtypes of cancers (hematological malignancy, breast cancer, colorectal cancer, esophageal cancer, renal cancer, gynecologic cancer, and liver cancer). Here, CXCR4 is linked to esophageal cancer.